scholarly article | Q13442814 |
P356 | DOI | 10.1111/CTR.12092 |
P698 | PubMed publication ID | 23414365 |
P2093 | author name string | Lars Pape | |
Martin Kreuzer | |||
Thurid Ahlenstiel | |||
Jan U Becker | |||
Nele K Kanzelmeyer | |||
P2860 | cites work | New equations to estimate GFR in children with CKD | Q24642417 |
Immunosuppressive drugs for kidney transplantation. | Q35992328 | ||
Minimizing the risk of chronic allograft nephropathy | Q37454291 | ||
De novoTherapy with Everolimus, Low‐Dose Ciclosporine A, Basiliximab and Steroid Elimination in Pediatric Kidney Transplantation | Q39837936 | ||
Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation | Q42635486 | ||
Improved late graft survival and half-lives in pediatric kidney transplantation: a single center experience | Q44249070 | ||
The natural history of chronic allograft nephropathy | Q44688416 | ||
Pretransplant dialysis status and outcome of renal transplantation in North American children: a NAPRTCS Study. North American Pediatric Renal Transplant Cooperative Study | Q45124379 | ||
Impact of cold ischemia time on renal allograft outcome using kidneys from young donors. | Q46531290 | ||
Reduced exposure to calcineurin inhibitors in renal transplantation | Q46840533 | ||
Cadaveric donor factor variations during a 12-year period: influence on kidney transplant outcomes. | Q51791031 | ||
Observational study with everolimus (Certican) in combination with low-dose cyclosporine in de novo heart transplant recipients. | Q52925202 | ||
P433 | issue | 2 | |
P304 | page(s) | 319-323 | |
P577 | publication date | 2013-02-17 | |
P1433 | published in | Clinical Transplantation | Q15754920 |
P1476 | title | Correlations with six-month protocol biopsy findings in pediatric transplant recipients on low- and regular-dose CNI regimens | |
P478 | volume | 27 |